Mid Atlantic Financial Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
Mid Atlantic Financial Management's DGX Position: Q3 2021 in Review
Mid Atlantic Financial Management increased its Quest Diagnostics (DGX) stake by 0.46% in Q3 2021, buying an estimated $1.61K and bringing the position to 2,381 shares worth $346K. The position accounts for 0.02% of the portfolio, ranked #603.
Mid Atlantic Financial Management first reported a position in DGX in Q2 2020 and has held it in 6 quarters since. The position peaked at $407K in Q1 2021. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.
- Mid Atlantic Financial Management held 2,381 shares of Quest Diagnostics worth $346K as of Q3 2021.
- Mid Atlantic Financial Management bought 11 Quest Diagnostics shares in Q3 2021, an estimated $1.61K.
- Quest Diagnostics made up 0.02% of Mid Atlantic Financial Management's portfolio in Q3 2021, its #603 holding.
- Mid Atlantic Financial Management first reported a position in Quest Diagnostics in Q2 2020 and has held it in 6 quarters since.
- Mid Atlantic Financial Management's Quest Diagnostics position peaked at $407K in Q1 2021.
- 838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.
Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.